On 4 November, our Principal, Ms. Pauli Wong, joined HKSTP Global Connect Market Discovery: Your Cross-Border Playbook as a panel speaker, sharing practical perspectives on navigating Hong Kong and the Greater Bay Area.

Pauli shared practical perspectives on building an IP strategy around business priorities, from early protection and market selection to commercialisation and cross-border expansion.

Thank you to HKSTP and the Global Connect team for the invitation and for bringing together entrepreneurs, innovators and ecosystem stakeholders for an engaging exchange.

我们的过去活动

Jennifer Che and Pauli Wong Co-Teach Advanced Patent Skills Seminar at HKU-TEC

2026年10月15日

Pauli Wong gave a talk at Hong Kong Life Sciences Society (HKLSS)

2026年10月10日

BioHK2026 | Biotech IP in practice

2026年9月16日

Jennifer Che Once Again Named to the IAM Strategy 300

2026年8月21日

Yolanda Wang attended the 1st China Pharmaceutical Innovation Conference

2026年7月22日

Pauli Wong as a Guest speaker for “Entrepreneurial Workshop” in Poly U

2026年6月16日

Recommended Insights

How Smart is a "Skilled Person in the Art"?

2022年4月11日
Let’s start with a riddle: can you name a person who has read every book, every journal, conducted every known experiment, and is knowledgeable about every single patent prosecution / litigation in the world? The answer? A “skilled person in the art.” This person is also known as a “person having ordinary skill in the […]
阅读更多 >

Interpreting the Stereochemistry of Phosphorus and Proving Commercial Success: How Gilead's Nucleoside Phosphoramidate Prodrug Patent "Captured" Sofosbuvir and Survived Invalidation

2026年11月9日
In pharmaceutical patent disputes, claim interpretation can be decisive because it defines the claimed subject matter against which novelty and inventive step are assessed. A single stereochemical notation in a structural formula may determine whether a patented claim covers a commercially successful drug worth billions of dollars. The dispute in the Gilead Sciences Inc. (hereinafter […]
阅读更多 >

US vs CN: Foreign Filing License Requirements

2022年11月9日
In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing. According to Chinese […]
阅读更多 >

From Faces to Football Fields: How Applying AI Models to Different Application Fields Can Prove Inventive in China

2025年10月21日
As AI models become versatile and adaptable across multiple contexts and industries, questions about inventive step sit at the heart of patent examination in China. The 2023 Patent Examination Guidelines (hereinafter referred to as 'the Guidelines') included several sessions dedicated to explaining how inventive step should be examined for AI-related inventions, featuring examples related to […]
阅读更多 >
Top crossarrow-right